Ujwal Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 38 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Satisfied Charges ₹ 3.31 M
- Revenue Growth 10.08%
- Profit Growth 25.74%
- Ebitda -69.91%
- Net Worth 30.40%
- Total Assets -8.45%
About Ujwal Pharma
Ujwal Pharma Pvt Ltd (UPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 August 1986 and has a history of 38 years and six months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹3.31 M, as per Ministry of Corporate Affairs (MCA) records.
Avinash Biyani and Kusum Biyani serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24200MH1986PTC040561
-
Company No.
040561
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Aug 1986
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Ujwal Pharma Pvt Ltd offer?
Ujwal Pharma Pvt Ltd offers a wide range of products and services, including Industrial Chemicals & Supplies, Chemical Intermediates, Flavours & Aromatics, Food Acidulant, Food Preservative, Chemical Compound, Potassium Benzoate, Ammonium Compound, Sodium Benzoate, Perfume Compounds.
Who are the key members and board of directors at Ujwal Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Biyani
|
Managing Director | 25-May-1998 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kusum Biyani
|
Director | 06-Aug-2024 | Current |
Financial Performance of Ujwal Pharma.
Ujwal Pharma Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 10.08% increase. The company also saw a substantial improvement in profitability, with a 25.74% increase in profit. The company's net worth Soared by an impressive increase of 30.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ujwal Pharma?
In 2022, Ujwal Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.00 M
₹3.31 M
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2017 | Others | ₹5.00 M | Open |
| 27 Jul 1995 | State Bank Of India | ₹2.35 M | Satisfied |
| 19 Jul 1988 | State Bank Of India | ₹0.96 M | Satisfied |
How Many Employees Work at Ujwal Pharma?
Unlock and access historical data on people associated with Ujwal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ujwal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ujwal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
